BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC. Provencio M, Robado de Lope L, Serna-Blasco R, Nadal E, et al. Lung Cancer 2024;194:107865.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Provencio M, Robado de Lope L, Serna-Blasco R, Nadal E, et al. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC. Lung Cancer 2024;194:107865.
PMID: 38945004